MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Familial neurodegenerative diseases"

  • 2025 International Congress

    Co-occurrence of Spinal Muscular Atrophy Type 2 and Huntington’s Disease

    U. Agarwal, S. Fu, Y. Wang, B. Bulica (Detroit, USA)

    Objective: To describe a unique case of co-occurring SMA2 and HD in a patient. Background: Huntington’s Disease (HD) is an autosomal dominant neurodegenerative disorder caused…
  • 2025 International Congress

    Detection and characterization of rare variants in NOTCH2NLC causing false negative molecular diagnosis through long-read sequencing

    N. Jin, X. Zheng, W. Luo (Hangzhou, China)

    Objective: This study investigated a NIID patient with typical clinical and imaging features but no detectable NOTCH2NLC GGC expansion using standard testing. Whole-genome long-read sequencing…
  • 2024 International Congress

    Implications of BSCL2 Mutation in the Pathogenesis of Parkinson’s Disease

    AY. Regalado-Mustafá, CF. álvarez-Hernandez, WF. Moguel-Cardin, AL. Guerra-Anzaldo, A. Domínguez-García, MAG. Medrano-Delgado, AJ. Hernández-Medrano, A. Cervantes-Arriaga, A. Abundes-Corona, A. Guevara-Salinas, M. Rodríguez-Violante, N. Monroy-Jaramillo, LV. Adalid-Peralta (Mexico City, Mexico)

    Objective: To report a case of a probable association between a mutation in the BSCL2 gene (Berardinelli-Seip Congenital Lipodystrophy 2) and Parkinson's disease (PD). Background:…
  • 2024 International Congress

    Long-read sequencing to identify unrevealed second hit in autosomal recessive Parkinson’s disease

    K. Daida, H. Yoshino, K. Billingsley, L. Malik, B. Baker, R. Genner, K. Paquette, M. Ishiguro, M. Funayama, Y. Li, K. Nishioka, C. Blauwendraat, N. Hattori (Bethesda, USA)

    Objective: Identify unrevealed variants in PRKN and PINK1 genes from young onset Parkinson’s disease (YOPD) patients. Background: Long-read sequencing has identified pathogenic repeats and structural…
  • 2024 International Congress

    Parkinson’s Families Project: A UK-Wide Study of Early Onset and Familial Parkinson’s Disease

    R. Real, Z-H. Fang, C. Towns, T. Schmaderer, S. Jasaityte, M. Tan, M. Pollard, L. Lange, R. Tilney, A. Singleton, C. Blauwendraat, C. Klein, H. Morris (London, United Kingdom)

    Objective: The Parkinson’s Families Project is a UK-wide study aimed at identifying genetic variation associated with familial and early-onset Parkinson's disease (PD). Background: Rare variants…
  • 2024 International Congress

    Clinical And Genetic Analysis Of Patients With Parkinson’s Disease -LRRK2 Variants From A Referral Centre In India

    S. Rath, PK. Pal, R. Yadav, VV. Holla, N. Kamble (MUMBAI, India)

    Objective: Our study aims to describe the clinical features and genetic profile of patients of PD carrying LRRK2 variants and draw correlation with genetic variants.…
  • 2024 International Congress

    Leveraging Large-Scale Proteomics to Identify Protein Quantitative Trait Loci and Causal Effects on Parkinson’s Disease

    M. Lai, B. Benitez (Boston, USA)

    Objective: Integrate proteomics from the cerebrospinal fluid (CSF) and urine from the Parkinson’s Progression Markers Initiative cohort to prioritize the risk variants associated with Parkinson’s…
  • 2024 International Congress

    Can Heterozygous Autosomal Recessive Mutations Cause Neurological Disease?

    L. Patil, M. Bhatt (Mumbai, India)

    Objective: To highlight the significance of heterozygous PLA2G6 and PRKN gene mutations in causing parkinsonism. Background: We report our observations in two families with multiple…
  • 2024 International Congress

    Phenotypic characterization of an ATP13A2 knockout rat model of Parkinson’s disease

    R. Kinet, J. Sikora, ML. Arotcarena, M. Decourt, E. Balado, E. Doudnikoff, E. Bezard, PO. Fernagut, B. Dehay (BORDEAUX, France)

    Objective: This project aimed to characterize the first-ever transgenic ATP13A2 knockout rat model to elucidate the underlying mechanisms of ATP13A2-associated pathology. Background: Most Parkinson’s disease…
  • 2024 International Congress

    Perry Syndrome due to a DCTN1 novel variant

    P. Lorenzo-Barreto, I. Muro-García, E. Casas-Peña, JP. Romero-Muñoz, L. López-Manzanares (Madrid, Spain)

    Objective: To report the clinical features of a patient with Perry syndrome (PS) due to a heterozygous novel pathogenic variant in the DCTN1 gene. Background:…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 16
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley